Return-on-Tangible-Equity is calculated as Net Income divided by its average total shareholder tangible equity. Total shareholder tangible equity equals to Total Stockholders Equity minus Intangible Assets. Bio Green Med Solution's annualized net income for the quarter that ended in Mar. 2026 was $-0.79 Mil. Bio Green Med Solution's average shareholder tangible equity for the quarter that ended in Mar. 2026 was $5.23 Mil. Therefore, Bio Green Med Solution's annualized Return-on-Tangible-Equity for the quarter that ended in Mar. 2026 was -15.06%.
The historical rank and industry rank for Bio Green Med Solution's Return-on-Tangible-Equity or its related term are showing as below:
BGMS'
s Return-on-Tangible-Equity Range Over the Past 10 Years
Min: -214.4 Med: -58.07 Max: -37.57
Current: -68.65
During the past 13 years, Bio Green Med Solution's highest Return-on-Tangible-Equity was -37.57%. The lowest was -214.40%. And the median was -58.07%.
BGMS's Return-on-Tangible-Equity is ranked worse than 62.8% of 1199
companies
in the Biotechnology industry
Industry Median: -42.4
vs BGMS: -68.65
Bio Green Med Solution (NAS:BGMS) Return-on-Tangible-Equity Explanation
Return-on-Tangible-Equity measures the rate of return on the ownership interest (shareholder's tangible equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' tangible equity (shareholders equity minus intangibles). Return-on-Tangible-Equity shows how well a company uses investment funds to generate earnings growth. Return-on-Tangible-Equitys between 15% and 20% are considered desirable.
Be Aware
Net Income is used.
Because a company can increase its Return-on-Tangible-Equity by having more financial leverage, it is important to watch the leverage ratio when investing in high Return-on-Tangible-Equity companies. Like Return-on-Tangible-Asset, Return-on-Tangible-Equity is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.
Asset light businesses require very few assets to generate very high earnings. Their Return-on-Tangible-Equitys can be extremely high.
Bio Green Med Solution Return-on-Tangible-Equity Related Terms
Bio Green Med Solution Return-on-Tangible-Equity Historical Data
* Premium members only.
The historical data trend for Bio Green Med Solution's Return-on-Tangible-Equity can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Bio Green Med Solution Return-on-Tangible-Equity Chart
BGMS vs GRI, PPCB, SPRC: Return-on-Tangible-Equity Comparison
For the Biotechnology subindustry, Bio Green Med Solution's Return-on-Tangible-Equity, along with its competitors' market caps and Return-on-Tangible-Equity data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Bio Green Med Solution Return-on-Tangible-Equity vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Bio Green Med Solution's Return-on-Tangible-Equity distribution charts can be found below:
* The bar in red indicates where Bio Green Med Solution's Return-on-Tangible-Equity falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual Return-on-Tangible-Equity, the net income of the last fiscal year and the average total shareholder tangible equity over the fiscal year are used. In calculating the quarterly data,
the net income data used here is four times the quarterly (Mar. 2026) net income data.
Return-on-Tangible-Equity is displayed in the 10-year financial page.
What does a Return-on-Tangible-Equity of -15.06% mean?
Bio Green Med Solution (BGMS) has a Return-on-Tangible-Equity of -15.06% as of Mar. 2026. Return on tangible equity is the ratio of current-period net income to average two-period tangible equity. View historical data on Bio Green Med Solution and its competitors. According to the industry distribution chart, Bio Green Med Solution ranks #753 out of 1199 companies in the Biotechnology industry, placing it in the top 62.8%.
Is Bio Green Med Solution's Return-on-Tangible-Equity too high?
Bio Green Med Solution's current Return-on-Tangible-Equity is -15.06%. Based on the distribution chart, Bio Green Med Solution ranks #753 out of 1199 companies in the Biotechnology industry, which is below the industry midpoint. Overall, Bio Green Med Solution has a GF Score™ of 47/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Bio Green Med Solution's Return-on-Tangible-Equity compare to GRI and PPCB?
According to the Biotechnology industry distribution chart, Bio Green Med Solution ranks #753 out of 1199 companies for Return-on-Tangible-Equity. This places Bio Green Med Solution in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Return-on-Tangible-Equity for a Biotechnology company?
A good Return-on-Tangible-Equity depends on the Biotechnology industry context. However, Return-on-Tangible-Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Return-on-Tangible-Equity mean?
A high Return-on-Tangible-Equity can signal that a stock is expensive relative to its fundamentals. Return on tangible equity is the ratio of current-period net income to average two-period tangible equity. View historical data on Bio Green Med Solution and its competitors. Bio Green Med Solution's current Return-on-Tangible-Equity is -15.06%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Bio Green Med Solution stock overvalued right now?
Based on GuruFocus' analysis, Bio Green Med Solution (BGMS) is currently considered Possible Value Trap. The stock's GF Value™ is $2.56, compared to a current price of $1.06 — trading 58.6% below its estimated fair value. The current Return-on-Tangible-Equity is -15.06%. Bio Green Med Solution's overall GF Score™ is 47/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Return-on-Tangible-Equity calculated?
Return-on-Tangible-Equity is calculated from a company's financial statements. For Bio Green Med Solution (BGMS), the current Return-on-Tangible-Equity is -15.06% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Bio Green Med Solution (BGMS) Overvalued in 2026?
Based on GuruFocus' analysis, Bio Green Med Solution stock appears to be undervalued.
The current stock price of $1.06 is trading 58.6% below its estimated GF Value™ of $2.56.
GuruFocus considers Bio Green Med Solution to be Possible Value Trap.
Key valuation signals for BGMS:
Return-on-Tangible-Equity: -15.06%
GF Value™: $2.56 vs. price of $1.06 (58.6% below fair value)
No single metric tells the full story. See the BGMS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Bio Green Med Solution Inc is engaged in the supply and trading of protective and fire safety equipment. The company distributes products such as fire extinguishers, foam systems, fire-resistant doors, personal protective equipment, and safety apparel. It also provides fire safety systems, including sprinkler systems, fire alarm systems, valves, and CO2 systems. The company operates across commercial, industrial, healthcare, and residential sectors, with a focus on distribution and compliance with applicable safety standards.
47GF Score
Get the complete analysis for BGMS
Return-on-Tangible-Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BGMS has been successfully added to your 
